American Society of Clinical Oncology - Clinical Cancer Advances 2017

Advance of the Year: Immunotherapy 2.0

Advances in Cancer Treatment Beyond Immunotherapy

Advances in Pacient Care

Advances in Tumor Biology

Cancer Risk, Prevention, and Screening

Looking to the Future

Advances in Cancer Treatment Beyond Immunotherapy - -

Artigo	Autor(es)	Referência
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.	Goss Paul E, Ingle James N, Pritchard Kathleen I, Robert Nicholas J, Muss Hyman, Gralow Julie, Gelmon Karen, Whelan Tim, Strasser-Weippl Kathrin, Rubin Sheldon, Sturtz Keren, Wolff Antonio C, Winer Eric, Hudis Clifford, Stopeck Alison, Beck J Thaddeus, Kaur Judith S, Whelan Kate, Tu Dongsheng, Parulekar Wendy R	The New England journal of medicine. 2016 Jul; 375(Jul):209-19. doi: 10.1056/NEJMoa1604700. pii: .

Nenhuma revista foi definida para este congresso.

Combined Modality Therapy	-
Longer Hormone Therapy Further Reduces Breast Cancer Recurrence	-
New Concerns About Laparoscopic Rectal Cancer Surgery	-
Targeted Therapy	-

Addressing Health Literacy in The Era of Precision Medicine	-
Better Way to Prevent Chemotherapy-Triggered Nause	-
Patient Navigation Program Improves Compliance With Cancer Therapy	-
Patient Self-Reporting of Symptoms Improves Care	-

Additional Genes Linked to Ovarian Cancer Risk	-
Broader Testing Uncovers Unexpected Cancer Predisposition Gene Mutations	-
Daily Vitamin B Reduces Skin Cancer Risk	-
Many Children With Cancer May Carry Hereditary Gene Mutations	-
New Understanding of Barriers to Cancer Screening Among Latinas	-
Pancreatic Cancer Susceptibility Genes Identified, and New Opportunities for Screening and Prevention	-

Checkpoint Inhibitors work well Against Hypermutated Cancers	-
Emerging Clues on Patient Selection	-
Progress With Immune Checkpoint Inhibitors 10	-

Expanding Targeted Therapy Options for Ovarian Cancer	-
Liquid Biopsies Help Personalize Cancer Therapy	-